Nisa Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-285
| Closed | -$191 | – | 2970 |
|
|
2024
Q1 | $191 | Buy |
+285
| New | +$207 | ﹤0.01% | 2651 |
|
|
2023
Q3 | – | Sell |
-89
| Closed | -$116 | – | 2823 |
|
|
2023
Q2 | $116 | Buy |
+89
| New | +$122 | ﹤0.01% | 2761 |
|
|
2023
Q1 | – | Sell |
-83
| Closed | – | – | 2688 |
|
|
2022
Q4 | $0 | Sell |
83
-60
| -42% | -$233 | ﹤0.01% | 2705 |
|
|
2022
Q3 | $1K | Buy |
+143
| New | +$735 | ﹤0.01% | 2498 |
|
|
2022
Q2 | – | Sell |
-3,000
| Closed | -$17K | – | 2496 |
|
|
2022
Q1 | $17K | Buy |
3,000
+1,665
| +125% | +$9.9K | ﹤0.01% | 2094 |
|
|
2021
Q4 | $8K | Sell |
1,335
-4,800
| -78% | -$41.7K | ﹤0.01% | 2057 |
|
|
2021
Q3 | $55 | Hold |
6,135
| – | – | ﹤0.01% | 1915 |
|
|
2021
Q2 | $73 | Hold |
6,135
| – | – | ﹤0.01% | 1829 |
|
|
2021
Q1 | $77 | Hold |
6,135
| – | – | ﹤0.01% | 1867 |
|
|
2020
Q4 | $96K | Buy |
6,135
+550
| +10% | +$6.44K | ﹤0.01% | 1745 |
|
|
2020
Q3 | $53K | Buy |
5,585
+4,300
| +335% | +$46.5K | ﹤0.01% | 1787 |
|
|
2020
Q2 | $12K | Buy |
1,285
+35
| +3% | +$325 | ﹤0.01% | 1885 |
|
|
2020
Q1 | $8K | Buy |
1,250
+250
| +25% | +$1.85K | ﹤0.01% | 1891 |
|
|
2019
Q4 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 1872 |
|
|
2019
Q3 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 1816 |
|
|
2019
Q2 | $11K | Buy |
1,000
+485
| +94% | +$5.16K | ﹤0.01% | 1735 |
|
|
2019
Q1 | $5K | Hold |
515
| – | – | ﹤0.01% | 1917 |
|
|
2018
Q4 | $6K | Hold |
515
| – | – | ﹤0.01% | 1777 |
|
|
2018
Q3 | $9K | Sell |
515
-360
| -41% | -$5.47K | ﹤0.01% | 1763 |
|
|
2018
Q2 | $12K | Buy |
875
+390
| +80% | +$6.48K | ﹤0.01% | 1679 |
|
|
2018
Q1 | $9K | Sell |
485
-675
| -58% | -$14.4K | ﹤0.01% | 1690 |
|
|
2017
Q4 | $19K | Hold |
1,160
| – | – | ﹤0.01% | 1562 |
|
|
2017
Q3 | $17K | Hold |
1,160
| – | – | ﹤0.01% | 1576 |
|
|
2017
Q2 | $10K | Sell |
1,160
-840
| -42% | -$5.39K | ﹤0.01% | 1721 |
|
|
2017
Q1 | $10K | Buy |
+2,000
| New | +$8.02K | ﹤0.01% | 1670 |
|
|
2016
Q4 | – | Sell |
-2,600
| Closed | -$12K | – | 1892 |
|
|
2016
Q3 | $12K | Sell |
2,600
-48,700
| -95% | -$248K | ﹤0.01% | 1774 |
|
|
2016
Q2 | $297K | Buy |
51,300
+30,000
| +141% | +$191K | ﹤0.01% | 1135 |
|
|
2016
Q1 | $129K | Buy |
+21,300
| New | +$128K | ﹤0.01% | 1305 |
|
|
2015
Q3 | – | Sell |
-23,300
| Closed | -$258K | – | 1290 |
|
|
2015
Q2 | $258K | Hold |
23,300
| – | – | ﹤0.01% | 1196 |
|
|
2015
Q1 | $365K | Buy |
23,300
+1,300
| +6% | +$20.1K | 0.01% | 1127 |
|
|
2014
Q4 | $335K | Hold |
22,000
| – | – | ﹤0.01% | 1120 |
|
|
2014
Q3 | $237K | Hold |
22,000
| – | – | ﹤0.01% | 1207 |
|
|
2014
Q2 | $336K | Hold |
22,000
| – | – | ﹤0.01% | 1153 |
|
|
2014
Q1 | $398K | Hold |
22,000
| – | – | 0.01% | 1116 |
|
|
2013
Q4 | $306K | Hold |
22,000
| – | – | ﹤0.01% | 1167 |
|
|
2013
Q3 | $231K | Buy |
+22,000
| New | +$218K | ﹤0.01% | 1226 |
|
Other funds holding SGMO
WA
AC
Nisa Investment Advisors's SGMO Position: Q2 2024 in Review
Nisa Investment Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 285 shares — an estimated $191 sold.
Nisa Investment Advisors first reported a position in SGMO in Q3 2013 and held it in 36 quarters. The position peaked at $398K in Q1 2014. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.
- Nisa Investment Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
- Nisa Investment Advisors sold 285 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $191.
- Nisa Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 36 quarters.
- Nisa Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $398K in Q1 2014.
- 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.
Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.